Jack A. Khattar
President, CEO, Director · SUPERNUS PHARMACEUTICALS, INC.
- 2024
- Aug 14, 2026
- 26
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Jack A. Khattar files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Padmanabh P. Bhatt - $5.39M in SUPN purchases and sales in the last 12 months
- Georges Gemayel - $1.00M in SUPN purchases and sales in the last 12 months
- William Todd Horich - $484K in SUPN purchases and sales in the last 12 months
- Frederick M. Hudson - $272K in SUPN purchases and sales in the last 12 months
- Bethany Sensenig - $228K in SUPN purchases and sales in the last 12 months
- Frank Mottola - $87K in SUPN purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Jack A. Khattar?
Jack A. Khattar is a corporate insider, tracked as President, CEO, Director of SUPERNUS PHARMACEUTICALS, INC. (SUPN). InsiderAlpha holds 26 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Jack A. Khattar submitted recently?
2 primary Form 4 filings in the last 90 days, covering 1 company.
Has Jack A. Khattar been buying or selling stock?
Recorded transactions: 0 open-market purchases and 22 open-market sales ($29.43M) across all tracked filings.
